Targeted Alpha Therapy (TAT) has emerged as one of the most powerful cancer treatment available thanks to its ability to cause large amounts of damage near a tumor cell while keeping the healthy surrounding tissue intact.
NIDC News
The DOE Isotope Program maintains an extensive inventory of radioactive and stable isotopes. These are a select few that are currently in inventory and ready to dispense to meet your research and commercial needs.
Representatives from the DOE Isotope Program (DOE IP) attended the 2nd International Workshop on Medical Radioisotope Supply, held on October 24-25, 2024, in Paris, France.
Christopher Landers’ path to the DOE Isotope Program wasn’t planned. Instead, passion, experience and a drive to make an impact gradually led him there.
DOE Isotope Program Highlights
Automated Nuclear Chemistry Boosts Astatine Production for Cancer Therapy
A team of researchers designed and tested an automated protocol aimed at reducing the At-211 processing procedure from dissolution of the irradiated target through column purification in just 20 minutes.
Spherical Powders Enable New Applications for Metals
Free-flowing metal powders offer improvements for additive manufacturing, isotope production target fabrication, and more.
New Understanding of Astatine’s Chemical Properties Will Aid Targeted Alpha Therapy for Cancer
Recently, scientists at Texas A&M University investigated astatine’s behavior when interacting with ion exchange and extraction chromatography resins.
